Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > its the TD trade show today

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Mar 29, 2021 7:52am

119 Views

Post# 32896873

its the TD trade show today

ecial terms and non-boardlot orders do not appear in Depth by Price +Vertical +Columnar +Horizontal

V:VXL Depth by Order @07:51:01

Bid			Ask
Broker	Size	Price	Price	Size	Broker
80 National Bank	1,000	0.125	0.125	820	7 TD Sec
7 TD Sec	1,720	0.125	0.125	164,000	7 TD Sec
7 TD Sec	27,500	0.12	0.125	375,000	7 TD Sec
7 TD Sec	16,000	0.12	0.13	16,000	1 Anonymous
68 Leede	5,000	0.12	0.13	12,500	2 RBC
1 Anonymous	8,000	0.12	0.13	1,500	124 Questrade
79 CIBC	10,000	0.12	0.135	15,000	7 TD Sec
80 National Bank	500	0.12	0.135	2,500	80 National Bank
7 TD Sec	21,000	0.12	0.135	88,000	80 National Bank
80 National Bank	2,000	0.12	0.135	61,500	80 National Bank